A carregar...

IMMU-20. EVALUATION OF CAR T CELLS IN EPENDYMOMA

BACKGROUND: Ependymoma is the third most common pediatric brain tumor and current treatment still results in a 10-year relapse rate of over 70% in the highest risk groups. The treatment refractory nature of ependymoma to standard therapies strongly supports the development of novel interventions. Ep...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Nellan, Anandani, Donson, Andrew, Calhoun, Jacob, Griesinger, Andrea, Fry, Terry, Foreman, Nicholas
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715269/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.376
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!